Improving Bone Marrow Transplants at Michigan Cancer Centers
BMT Core- University of Michigan Core Clinical Consortium for the BMT Clinical Trials Network (BMT CTN)
This grant helps connect leading cancer centers in Michigan to offer patients advanced bone marrow transplant options through clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11166602 on NIH RePORTER |
What this research studies
This grant supports a collaborative effort between the University of Michigan and Karmanos Cancer Institute, two major cancer centers in Michigan. Their goal is to conduct clinical trials that improve bone marrow transplantation for patients with blood cancers and other blood disorders. They are particularly interested in finding new ways to prevent common transplant complications, such as graft-versus-host disease and organ damage. This work aims to make bone marrow transplants safer and more effective for those who need them.
Who could benefit from this research
Good fit: Patients with certain blood cancers or non-malignant blood disorders who are considering or undergoing bone marrow transplantation, including both adults and children, may be ideal candidates.
Not a fit: Patients who are not undergoing or considering bone marrow transplantation would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that reduce transplant-related side effects and improve long-term health for patients undergoing bone marrow transplantation.
How similar studies have performed: The consortium has a strong track record of enrolling many subjects into clinical trials, indicating established success within the network, while also exploring new treatment approaches.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Yanik, Gregory a — University of Michigan at Ann Arbor
- Study coordinator: Yanik, Gregory a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.